Traditional cigarette sales volumes continue to fall, but the tobacco giant is compensating with its newer nicotine products.

Philip Morris International shares sank Tuesday after the tobacco giant missed quarterly sales estimates as demand for ...

Philip Morris shares dropped 7% after Q2 revenue missed expectations due to weaker cigarette sales and lower-than-forecast ...

Morgan Stanley sees Philip Morris' post-earnings dip as a buying opportunity, citing IQOS growth, Zyn momentum, and long-term potential.

Philip Morris’ revenue of $8.8 billion in Q1 was up 10% y-o-y. Heated Tobacco Unit shipment volume was up a solid 21%, oral products volume was up 36%, which more than offset a 0.4% decline in ...

Philip Morris said Iqos sales outpaced Marlboro for the first time. Overall revenue growth was solid, but earnings missed estimates. Management sees adjusted EPS growing 7% to 9% next year. As a ...

Philip Morris aims to garner 10-15% of its sales from its Reduced-Risk Products (RRPs) portfolio within a decade. It is betting on one such product, iQOS, and feels it will become more popular ...

Philip Morris International Inc. PM is treading with an impressive pace on its smoke-free journey. The tobacco giant recently submitted Premarket Tobacco Product Applications (PMTAs) and Modified ...

Separately, Altria Group Inc. said Philip Morris agreed to pay $2.7 billion for the US rights to sell its IQOS device. The new offer for Swedish Match, a smokeless tobacco company, will come as ...